These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38734211)

  • 1. Lectibodies as antivirals.
    Santisteban Celis IC; Matoba N
    Antiviral Res; 2024 Jul; 227():105901. PubMed ID: 38734211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lectins and lectibodies: potential promising antiviral agents.
    Nabi-Afjadi M; Heydari M; Zalpoor H; Arman I; Sadoughi A; Sahami P; Aghazadeh S
    Cell Mol Biol Lett; 2022 May; 27(1):37. PubMed ID: 35562647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and Efficacy of Avaren-Fc Lectibody Targeting HCV High-Mannose Glycans in a Human Liver Chimeric Mouse Model.
    Dent M; Hamorsky K; Vausselin T; Dubuisson J; Miyata Y; Morikawa Y; Matoba N
    Cell Mol Gastroenterol Hepatol; 2021; 11(1):185-198. PubMed ID: 32861832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiviral Cyanometabolites-A Review.
    Mazur-Marzec H; Cegłowska M; Konkel R; Pyrć K
    Biomolecules; 2021 Mar; 11(3):. PubMed ID: 33810129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mannose-specific plant and microbial lectins as antiviral agents: A review.
    Gupta A; Yadav K; Yadav A; Ahmad R; Srivastava A; Kumar D; Khan MA; Dwivedi UN
    Glycoconj J; 2024 Feb; 41(1):1-33. PubMed ID: 38244136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyanobacterial lectins characteristics and their role as antiviral agents.
    Singh RS; Walia AK; Khattar JS; Singh DP; Kennedy JF
    Int J Biol Macromol; 2017 Sep; 102():475-496. PubMed ID: 28437766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Legume Lectins with Different Specificities as Potential Glycan Probes for Pathogenic Enveloped Viruses.
    Barre A; Van Damme EJM; Klonjkowski B; Simplicien M; Sudor J; Benoist H; Rougé P
    Cells; 2022 Jan; 11(3):. PubMed ID: 35159151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Engineering of a Lectibody Targeting High-Mannose-Type Glycans of the HIV Envelope.
    Hamorsky KT; Kouokam JC; Dent MW; Grooms TN; Husk AS; Hume SD; Rogers KA; Villinger F; Morris MK; Hanson CV; Matoba N
    Mol Ther; 2019 Nov; 27(11):2038-2052. PubMed ID: 31471224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of glycoengineering and antidrug antibodies on the anticancer activity of a plant-made lectin-Fc fusion protein.
    Dent M; Mayer KL; Verjan Garcia N; Guo H; Kajiura H; Fujiyama K; Matoba N
    Plant Biotechnol J; 2022 Nov; 20(11):2217-2230. PubMed ID: 35900183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Complex-Type
    Mu J; Hirayama M; Morimoto K; Hori K
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiviral Strategies Using Natural Source-Derived Sulfated Polysaccharides in the Light of the COVID-19 Pandemic and Major Human Pathogenic Viruses.
    Ray B; Ali I; Jana S; Mukherjee S; Pal S; Ray S; Schütz M; Marschall M
    Viruses; 2021 Dec; 14(1):. PubMed ID: 35062238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring lectin-glycan interactions to combat COVID-19: Lessons acquired from other enveloped viruses.
    Nascimento da Silva LC; Mendonça JSP; de Oliveira WF; Batista KLR; Zagmignan A; Viana IFT; Dos Santos Correia MT
    Glycobiology; 2021 May; 31(4):358-371. PubMed ID: 33094324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody glycosylation and its impact on the pharmacokinetics and pharmacodynamics of monoclonal antibodies and Fc-fusion proteins.
    Liu L
    J Pharm Sci; 2015 Jun; 104(6):1866-1884. PubMed ID: 25872915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NICTABA and UDA, two GlcNAc-binding lectins with unique antiviral activity profiles.
    Gordts SC; Renders M; Férir G; Huskens D; Van Damme EJ; Peumans W; Balzarini J; Schols D
    J Antimicrob Chemother; 2015; 70(6):1674-85. PubMed ID: 25700718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lectins engineered to favor a glycan-binding conformation have enhanced antiviral activity.
    Matoba Y; Sato Y; Oda K; Hatori Y; Morimoto K
    J Biol Chem; 2021; 296():100698. PubMed ID: 33895142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycan-dependent chikungunya viral infection divulged by antiviral activity of NAG specific chi-like lectin.
    Kaur R; Neetu ; Mudgal R; Jose J; Kumar P; Tomar S
    Virology; 2019 Jan; 526():91-98. PubMed ID: 30388630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lectins purified from medicinal and edible mushrooms: Insights into their antiviral activity against pathogenic viruses.
    El-Maradny YA; El-Fakharany EM; Abu-Serie MM; Hashish MH; Selim HS
    Int J Biol Macromol; 2021 May; 179():239-258. PubMed ID: 33676978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant chimeric lectins consisting of mannose-binding lectin and L-ficolin are potent inhibitors of influenza A virus compared with mannose-binding lectin.
    Chang WC; Hartshorn KL; White MR; Moyo P; Michelow IC; Koziel H; Kinane BT; Schmidt EV; Fujita T; Takahashi K
    Biochem Pharmacol; 2011 Feb; 81(3):388-95. PubMed ID: 21035429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting the glycans of glycoproteins: a novel paradigm for antiviral therapy.
    Balzarini J
    Nat Rev Microbiol; 2007 Aug; 5(8):583-97. PubMed ID: 17632570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Broad-Spectrum Antiviral Entry Inhibition by Interfacially Active Peptides.
    Hoffmann AR; Guha S; Wu E; Ghimire J; Wang Y; He J; Garry RF; Wimley WC
    J Virol; 2020 Nov; 94(23):. PubMed ID: 32907984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.